1 documents found
Information × Registration Number 0217U002100, 0115U000312 , R & D reports Title Determination of clinical and hematological, immunological and cytogenetic predictors of prognosis of myelodysplastic syndrome popup.stage_title Head Tretyak N.M., Доктор медичних наук Registration Date 18-01-2017 Organization Kiev Research Institute of Haematolojy and Blood Transfusion popup.description2 The object of study: 48 patients with MDS. Methods: clinical, cytological, immunological, imunofenotipichni, cytogenetic, statistics. It is found that the determine of immunophenotype of bone marrow cells by flow cytometry with MDS, such as the intensity of CD 33, CD 34, CD 117, and the expression of Ki-67 cells of myeloid germ has a high diagnostic and prognostic value in patients treated with cytostatic therapy. Our studies show that nuclear proliferation factor Ki-67 is a promising potential predictor of progression of MDS and its transformation in AML, and factor in the formation of certain clinical and hematological features of the disease. Medicine. Product Description popup.authors Андреєва Світлана Василівна Басова Ольга Василівна Гордієнко Алла Іванівна Коваль Альвіна Іванівна Кубарова Валентина Олександрівна Стародуб Галина Сергіївна popup.nrat_date 2020-04-02 Close
R & D report
Head: Tretyak N.M.. Determination of clinical and hematological, immunological and cytogenetic predictors of prognosis of myelodysplastic syndrome. (popup.stage: ). Kiev Research Institute of Haematolojy and Blood Transfusion. № 0217U002100
1 documents found

Updated: 2026-03-20